Riskpilot← Back to searchSign inGet full accessDELE HEALTH TECH AS
ASActiveOrg 996547108Strandgata 29, 8656 MosjøenComputing infrastructure, data processing, hosting and related activities · NACE 6310Est. 20110 employeeswww.delehealth.com
Revenue 2024
NOK 0
EBITDA margin
—
-101% vs 2023
Equity ratio
99.3%
Financial strength
Net profit 2024
NOK -186,7M
-509% vs 2023
| Revenue | NOK 0 | — |
| EBITDA | NOK -443K | -101% |
| Net profit | NOK -186,7M | -509% |
| Total assets | NOK 12M | -94% |
| Equity | NOK 11,9M | -94% |
| Employees | 0 | — |
Legal name
DELE HEALTH TECH AS
Org number
996547108
Legal form
Aksjeselskap
NACE code
6310 · Computing infrastructure, data processing, hosting and related activities
Founded
10. februar 2011
Share capital
NOK 58 424 004
Employees
0
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
To styremedlemmer i fellesskap. Daglig leder og styrets leder i fellesskap.
Company purpose
Eie aksjer og andeler i andre selskaper og det som står i forbindelse med slik virksomhet.
Address
Strandgata 29, 8656 Mosjøen
Email
hello@delehealth.com
Website
www.delehealth.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 254 | 406 | 717 | 51 216 | 0 |
| Staff expenses | −1 755 | −6 329 | −6 555 | −2 578 | −0 |
| EBITDA | −13 950 | −26 854 | −31 456 | 43 352 | −443 |
| Depreciation & amort. | −0 | −35 | −71 | −99 | −21 |
| EBIT | −13 950 | −26 889 | −31 527 | 43 253 | −464 |
| Net financials | −24 | 321 | 5 827 | 2 395 | −186 229 |
| Profit before tax | −13 974 | −26 568 | −25 700 | 45 648 | −186 693 |
| Tax | −0 | −0 | −0 | −0 | −0 |
| Net profit | −13 974 | −26 568 | −25 700 | 45 648 | −186 693 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 16 327 | 79 826 | 121 205 | 198 947 | 11 956 |
| Equity | 9 770 | 72 745 | 97 216 | 198 563 | 11 870 |
| Long-term debt | 429 | 166 | 0 | 0 | 0 |
| Short-term debt | 6 128 | 6 915 | 23 988 | 384 | 86 |
| Total debt | 6 557 | 7 081 | 23 988 | 384 | 86 |
EBITDA margin
-44329000.0%
This company
15.8%
Market median
-280563391% vs market
20202024
Equity ratio
99.3%
This company
38.2%
Market median
+160% vs market
20202024
Return on equity
-1572.8%
This company
18.4%
Market median
-8648% vs market
20202024
Net profit margin
-18669308300.0%
This company
8.1%
Market median
-230485287754% vs market
20202024
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20202024
Debt / equity
0.01×
This company
0.62×
Market median
+98% vs market
20202024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Former (2) | ||
SE Chief Executive Officer | Chief Executive Officer | 2022 – 2023 |
CZ Chief Executive Officer | Chief Executive Officer | 2019 – 2022 |
| Name | Role | Member since |
|---|---|---|
| Current (4) | ||
| Board of Directors | 2023 | |
| Chairman | 2025 | |
| Board of Directors | 2023 | |
| Board of Directors | 2023 | |
| Former (6) | ||
| Board of Directors | 2022 – 2023 | |
| Chairman | 2022 – 2023 | |
| Chairman | 2023 – 2025 | |
| Board of Directors | 2022 – 2023 | |
| Board of Directors | 2022 – 2023 | |
| Board of Directors | 2023 – 2025 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 36.95% | 36.95% | 2024 | |
| Company | 10.24% | 10.24% | 2024 | |
Northscaler Inc. | Company | 9.31% | 9.31% | 2024 |
| Company | 5.83% | 5.83% | 2024 | |
| Company | 5.74% | 5.74% | 2024 | |
| Company | 5.32% | 5.32% | 2024 | |
| Company | 3.61% | 3.61% | 2024 | |
| Company | 3.14% | 3.14% | 2024 | |
| Company | 2.05% | 2.05% | 2024 | |
| Company | 1.79% | 1.79% | 2022 | |
| Company | 1.74% | 1.74% | 2024 | |
| Company | 1.41% | 1.41% | 2024 | |
| Company | 1.12% | 1.12% | 2024 | |
| Company | 1.1% | 1.1% | 2024 | |
| Company | 1.07% | 1.07% | 2024 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of DELE HEALTH TECH AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Susan Elizabeth Hagerty Bonsak | Chief Executive Officer | 0 companies |
| Carine Zeier | Chief Executive Officer | 0 companies |
| Hans Othar Blix | Board of Directors | 0 companies |
| Audun Grynning | Board of Directors | 0 companies |
| Rami Haug Khoury | Chairman | 0 companies |
| Pål Sommer Breiland | Chairman | 0 companies |
| Tor Helmersen | Chairman | 0 companies |
| Gaute Eskil Engbakk | Board of Directors | 0 companies |
| Tatiana Vladimirovna Budkova | Board of Directors | 0 companies |
| Arve Janbu Fresvik | Board of Directors | 0 companies |
| Olaf Magnus Strøm Haavik | Board of Directors | 0 companies |
| Hans Christian Dall Nygård | Board of Directors | 0 companies |